Gryphon Capitalome Trust (ASX:GCI) Research & Development: A$0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:GCI Gryphon Capital Income Trust ASX:GCI
77 GF Score
Price A$2.07
GF Value A$2.14
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Gryphon Capitalome Trust Research & Development?

Gryphon Capitalome Trust ASX:GCI 77 Research & Development is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:GCI with a GF Score™ of 77/100 and a GF Value™ of A$2.14 (Fairly Valued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Gryphon Capitalome Trust's Research & Development for the six months ended in Dec. 2025 was A$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.

Gryphon Capitalome Trust  (ASX:GCI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Gryphon Capitalome Trust Research & Development Related Terms

Gryphon Capitalome Trust Research & Development Historical Data

* Premium members only.

The historical data trend for Gryphon Capitalome Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gryphon Capitalome Trust Research & Development Chart

Gryphon Capitalome Trust Annual Data
Trend Jun17 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Gryphon Capitalome Trust Semi-Annual Data
Jun17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:GCI
77GF Score
Gryphon Capital Income Trust ASX:GCI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gryphon Capitalome Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$0.00 Mil mean?
Gryphon Capitalome Trust (ASX:GCI) has a Research & Development of A$0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Gryphon Capitalome Trust and its competitors.
Is Gryphon Capitalome Trust's Research & Development too high?
Gryphon Capitalome Trust's current Research & Development is A$0.00 Mil. Overall, Gryphon Capitalome Trust has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gryphon Capitalome Trust's Research & Development compare to BLK and BX?
Gryphon Capitalome Trust's Research & Development of A$0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Gryphon Capitalome Trust and its competitors. Gryphon Capitalome Trust's current Research & Development is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gryphon Capitalome Trust stock overvalued right now?
Based on GuruFocus' analysis, Gryphon Capitalome Trust (ASX:GCI) is currently considered Fairly Valued. The stock's GF Value™ is A$2.14, compared to a current price of A$2.07 — trading 3.3% below its estimated fair value. The current Research & Development is A$0.00 Mil. Gryphon Capitalome Trust's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Gryphon Capitalome Trust (ASX:GCI), the current Research & Development is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gryphon Capitalome Trust (ASX:GCI) Overvalued in 2026?

Based on GuruFocus' analysis, Gryphon Capitalome Trust stock appears to be undervalued. The current stock price of A$2.07 is trading 3.3% below its estimated GF Value™ of A$2.14. GuruFocus considers Gryphon Capitalome Trust to be Fairly Valued.

Key valuation signals for ASX:GCI:

  • Research & Development: A$0.00 Mil
  • GF Value™: A$2.14 vs. price of A$2.07 (3.3% below fair value)
  • GF Score™: 77/100 with 8 warning signs

No single metric tells the full story. See the ASX:GCI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gryphon Capitalome Trust Business Description

Address 1 Farrer Place, Level 16, Governor Macquarie Tower, Sydney, NSW, AUS, 2000
Gryphon Capital Income Trust is a managed investment scheme. Its investment objective is to produce regular and sustainable monthly income while keeping capital preservation as a primary concern. The trust invests in a diversified portfolio of residential mortgage-backed securities (RMBS) and asset-backed securities (ABS) issued by Australian-domiciled entities. It is organised into one main operating segment with only one key function, being the investment of funds predominantly in Australia.
77GF Score

Get the complete analysis for ASX:GCI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.07
Price
A$2.14
GF Value